<DOC>
	<DOCNO>NCT01000662</DOCNO>
	<brief_summary>All patient ( Stages 0-II breast cancer ) receive accelerate three week regimen prone whole breast radiotherapy . The study intend test hypothesis weekly boost tumor bed , deliver Friday , weekend break , well tolerated daily boost accelerate prone radiotherapy .</brief_summary>
	<brief_title>Study Comparing Whole Breast Radiotherapy With Daily Versus Weekly Tumor</brief_title>
	<detailed_description>Arm 1 concomitant boost protocol three week previously evaluate 500 patient ( NYU 03-30 NYU 05-181 ) show excellent tolerance , result . Arm 2 evaluates Weekend Boost Dose ( WBD ) regimen may radiobiological advantage counteract tumor repopulation occur weekend break . At time registration study , patient randomize either treatment arm stratify accord pre post-menopausal status previous chemotherapy receive .</detailed_description>
	<criteria>Pre postmenopausal woman stage 0 , I , II breast cancer Biopsyproven invasive breast cancer , excise negative margin least 1 mm Status post segmental mastectomy , sentinel node biopsy and/or axillary node dissection ( DCIS Tumors &lt; 5mm require nodal assessment ) At least 2 week last chemotherapy Patient need able understand demonstrate willingness sign write informed consent document Previous radiation therapy ipsilateral breast More 3 involved node identify axillary staging , require adjuvant axillary radiation Active connective tissue disorder , lupus scleroderma Prior concurrent malignancy basal squamous cell skin cancer carcinoma insitu cervix , unless diseasefree &gt; 3 year Pregnant lactating woman</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>whole breast radiotherapy</keyword>
	<keyword>tumor bed boost</keyword>
</DOC>